Company Quick10K Filing
Boston Therapeutics
10-Q 2020-09-30 Filed 2020-12-28
10-Q 2020-06-30 Filed 2020-12-17
10-Q 2020-03-31 Filed 2020-11-30
10-K 2019-12-31 Filed 2020-06-08
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-11
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-20
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-13
10-K 2013-12-31 Filed 2014-03-14
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-04
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-18
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-01
10-Q 2010-09-30 Filed 2010-11-23
8-K 2020-05-15
8-K 2020-04-14
8-K 2020-01-10
8-K 2019-12-12
8-K 2019-12-02
8-K 2019-09-24
8-K 2018-11-30
8-K 2018-06-26
8-K 2018-06-12
8-K 2018-06-01
8-K 2018-02-12

Boston Therapeutics Financials

BTHE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash33622626418169552385133,8643,3872,5121,5095691572202085841412192368739013229713720536311128119
Accounts Receivable81721121710043094031358511111110010
Inventory1224252524172516519011198173178198180127186110104103100555554423937321876
PP&E47799101518181714131198643243343332211
Assets1,2611,1509431,3171,0641,4351,3021,0605,1344,5353,4702,5661,7041,1631,2351,1261,0138788531,1711,6971,4051,0991,0471,1879043,4814,0984,2931,439930821743
Accounts Payable2173423213363522943563641151717296287411519659859575554523287319350297271299527481524510551595592
Long-Term Debt4974971,6021,7521,75236559379300
Liabilities6167257027688087398118346401,1906127929601,0881,4992,1371,6951,4091,4011,6976,4974,5244,9134,6655,6434,7875,9206,5775,8445,5855,9926,1516,362
Stockholders' Equity6454252415492566964902264,4943,3452,8571,77474375-264-1,011-682-531-548-526-4,801-3,119-3,815-3,618-4,456-3,884-3,577-3,616-2,688-4,146-5,061-5,329-5,619
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue11192131923232188044211211351395412161259454159138454
Cost of Revenue3128229164829119104552282173267509216917529618
Gross Profit-2-0-9-2-73-25-699-23-11-139-419-28-45-87-48-66-4-1-13
R&D94675268112332922152342269530519232205974742220162642481896438540488383387
SG&A2482151922065745436097821,0571,9281,2781,014674520549386371301233166495292249203264351680726316245227257
Tax000000003011500-140-440000000000
Net Income-349-286-257-191-366-578-667-519-1,117-2,298-1,566-1,211-1,160-762-676-686-534-593-419-368-4,6201,669-7084,022-972-16-2,743-132765-952-282-303
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-110-200-166-245-242-415-372-1,036-516-1,121-1,001-939-412-369-12-246-667-402-169-442-236-294-453-255-211-269-31-54-386-404
Cash Investing00-4-3-20-2-6-4-2000000000-30-1400000
Cash Financing00562062525004,889462500004320976504021501,34401959627510030650389402